News | News By Subject | News by Disease News By Date | Search News

Breast Cancer News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Exciting Time for Biotech in New Jersey     6/29/2015
ASCO15 EXCLUSIVE: Berg’s Lead Cancer Drug May Shift Cancer Metabolism, Says CEO     6/4/2015
ASCO15 EXCLUSIVE: Merck & Co. (MRK)’s Breast Cancer Drug Beats Chemo Rates and Will Roll Into Phase III, Says Investigator     6/1/2015
ASCO15: Pfizer (PFE)'s Ibrance Slows Progression of Breast Cancer in Late-Stage Study     6/1/2015
Puma Biotech (PBYI) Founder Loses $250 Million on Disappointing Breast Cancer Drug Data     5/15/2015
Pfizer (PFE) Beams As Cancer Drug Efficacy Stops Trial Early and Analysts Predict Game Changer     4/17/2015
Roche (RHHBY) Says 11 Late-Stage Cancer Drugs Will Enter Trials in 2015     4/15/2015
Nektar Therapeutics (NKTR) Cancer Drug Improves Survival But Misses Primary Endpoint, As Watchers Worry     3/20/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
100 Pfizer (PFE) Scientists and Their Journey to Bring Ibrance to Market     3/10/2015
Analyst: Docs Bullish On Roche (RHHBY)'s Perjeta and PD-1/PDL1, Cautious on Palbociclib and Neratinib     3/5/2015
Genentech (RHHBY)'s Breast Cancer Cocktail Buys More Than a Year of Life     2/25/2015
FDA Green Lights Pfizer (PFE)'s High Profile Breast Cancer Drug Two Months Early     2/5/2015
Roche (RHHBY) Suffers A Double Blow As Breast Cancer, Alzheimer’s Drug Studies Fail; Pulls Plug On ALZ's Drug Development     12/23/2014
Merck & Co. (MRK)'s Keytruda Shrank Tumors In Hard-To-Treat Breast Cancer Patients     12/11/2014

News from Around the Web
Helmholtz Center In Munich Scientists Growing Mini Breasts To Study Cancer     6/15/2015
Soyfoods Reduce Breast Cancer Recurrence, University Medical Center Study     4/20/2015
Cancer Research Uncovers The Fountain Of Youth, University of Toronto Study     4/10/2015
How Artificial Light Can Mess With Your Health, University of Connecticut Researchers Say     3/20/2015
Genentech (RHHBY) Dives Into Apps to Help Cancer Patients     3/4/2015
A New Weapon In The Fight Against Cancer, Concordia University Reveals     2/20/2015
Unhealthy Insulin Levels May Boost Breast Cancer Risk, Imperial College London Study     1/16/2015
Hold Your Breath To Protect Your Heart, Thomas Jefferson University Study     1/7/2015
Low-Fat Diet May Help Women Survive Breast Cancer, UCLA Medical Center Study     12/16/2014
No Link Between Migraine, Breast Cancer Risk, Harvard University Study Says     12/15/2014
A*STAR Scientists Uncover Gene Associated With An Aggressive Breast Cancer     12/2/2014
Increasing Skirt Size Boosts Your Breast Cancer Risk, University College London Study     9/26/2014
Is Soy A Foe To Women With Breast Cancer? Memorial Sloan-Kettering Cancer Center Study     9/8/2014
Bras Cause Breast Cancer? Apparently Not, Fred Hutchinson Cancer Research Center Study     9/5/2014
Study Ties New Gene Mutation To Major Breast Cancer Risk, The New England Journal of Medicine Reveals     8/7/2014

Press Releases
GC Aesthetics Files For A $75 Million IPO     6/25/2015
TapImmune Inc. (TPIV) Reports Robust Immune Responses Generated In 19 Of 20 Evaluable HER2/Neu Breast Cancer Patients     6/23/2015
Merrimack (MACK) Announces Expansion Of MM-398 (nal-IRI) Imaging Study To Patients With Metastatic Breast Cancer     6/12/2015
U.S. FDA Reactivates Prescient Therapeutics's IND For PTX-100 Breast Cancer Trial     6/10/2015
Navidea (NAVB) Reports Positive Lymphoseek Comparative Results In Injection Site Pain Study In Breast Cancer     6/9/2015
University at Albany Researcher Explores Link Between Vitamin D, Breast Cancer Treatment     6/8/2015
ASCO15: Ascentia Pharma Inc. Release: New Enzalutamide Data In Triple-negative Breast Cancer Presented At The 2015 American Society Of Clinical Oncology Annual Meeting     6/2/2015
ASCO15: Pfizer (PFE) Announces Palbociclib More Than Doubled Progression-Free Survival In Phase 3 Trial For Patients With HR+, HER2- Metastatic Breast Cancer Whose Disease Has Progressed Following Endocrine Therapy     6/1/2015
ASCO15: Immunomedics, Inc. (IMMU) Reports Complete Responses In Patients With Metastatic Triple-Negative Breast Cancer After Sacituzumab Govitecan Treatment     6/1/2015
ASCO: Puma Biotech (PBYI) Announces Phase III Trial Of PB272 In Extended Adjuvant Breast Cancer (Extenet Trial) Demonstrates Statistically Significant Improvement In Disease Free Survival     6/1/2015
Merck & Co. (MRK)’s MK-2206 "Graduates" From I-SPY 2 Breast Cancer Trial Showing Benefit For HER2+ And Hormone-Receptor Negative Breast Cancer     6/1/2015
Roche (RHHBY)’s Perjeta Regimen Helped People With HER2-Positive Early Breast Cancer Live Longer Without Their Disease Returning Or Getting Worse Compared To Herceptin And Chemotherapy     6/1/2015
ASCO15: AngioChem Presents ANG1005 Data On Breast Cancer Patients With Brain Metastasis At The 2015 American Society For Clinical Oncology Annual Meeting     6/1/2015
ASCO15: MacroGenics, Inc. (MGNX) Presents Updated Data From Phase I Study Of Margetuximab At ASCO Annual Meeting 2015     6/1/2015
ASCO15: Oncothyreon Inc. (ONTY) Announces Presentation Of Positive ONT-380 Data In HER2-Positive Breast Cancer At ASCO Annual Meeting And Updates Development Plan     6/1/2015